62
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

Dna Hypomethylation And Upregulated LINC00518 Acts As A Promoter And Biomarker In Head And Neck Squamous Cell Carcinoma

, , , , , & ORCID Icon show all
Pages 293-306 | Received 15 Feb 2023, Accepted 24 Apr 2023, Published online: 17 May 2023

References

  • Johnson DE , BurtnessB , LeemansCR , LuiV , BaumanJE , GrandisJR. Head and neck squamous cell carcinoma. Nat. Rev. Dis. Primers6(1), 92 (2020).
  • Pazhani J , VeeraraghavanVP , JayaramanS. Transcription factors: a potential therapeutic target in head and neck squamous cell carcinoma. Epigenomics15(2), 57€“60 (2023).
  • Xue Y , JiangX , WangJet al. Effect of regulatory cell death on the occurrence and development of head and neck squamous cell carcinoma. Biomark. Res.11(1), 2 (2023).
  • Ghafouri-Fard S , Mohammad-RahimiH , JazaeriM , TaheriM. Expression and function of long non-coding RNAs in head and neck squamous cell carcinoma. Exp. Mol. Pathol.112, 104353 (2020).
  • Jiang Y , WuK , CaoWet al. Long noncoding RNA KTN1-AS1 promotes head and neck squamous cell carcinoma cell epithelial€“mesenchymal transition by targeting miR-153-3p. Epigenomics12(6), 487€“505 (2020).
  • Jiang M , LiuF , YangAG , WangW , ZhangR. The role of long non-coding RNAs in the pathogenesis of head and neck squamous cell carcinoma. Mol. Ther. Oncolytics24, 127€“138 (2022).
  • Eptaminitaki GC , StellasD , BonavidaB , BaritakiS. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: from prediction to druggability. Drug Resist. Update65, 100866 (2022).
  • Yang J , LiuF , WangY , QuL , LinA. LncRNAs in tumor metabolic reprogramming and immune microenvironment remodeling. Cancer Lett.543, 215798 (2022).
  • Akbari DN , KhoshsiratS , Shanaki-BavarsadM , Pourbagheri-SigaroodiA , BashashD. The contributory role of long non-coding RNAs (lncRNAs) in head and neck cancers: possible biomarkers and therapeutic targets?Eur. J. Pharmacol.900, 174053 (2021).
  • Sannigrahi MK , SharmaR , PandaNK , KhullarM. Role of non-coding RNAs in head and neck squamous cell carcinoma: a narrative review. Oral Dis.24(8), 1417€“1427 (2018).
  • Tan YT , LinJF , LiT , LiJJ , XuRH , JuHQ. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun.41(2), 109€“120 (2021).
  • Luo H , JiangQ , LuoYet al. Comprehensive analysis of ESR1-related ceRNA axis as a novel prognostic biomarker in hepatocellular carcinoma. Epigenomics14(22), 1393€“1409 (2022).
  • Xu YJ , ZhaoJM , NiXF , WangW , HuWW , WuCP. LncRNA HCG18 suppresses CD8+ T cells to confer resistance to cetuximab in colorectal cancer via miR-20b-5p/PD-L1 axis. Epigenomics13(16), 1281€“1297 (2021).
  • Yu Z , TangH , ChenSet al. Exosomal LOC85009 inhibits docetaxel resistance in lung adenocarcinoma through regulating ATG5-induced autophagy. Drug Resist. Update67, 100915 (2023).
  • Jiang M , QiF , ZhangKet al. MARCKSL1-2 reverses docetaxel-resistance of lung adenocarcinoma cells by recruiting SUZ12 to suppress HDAC1 and elevate miR-200b. Mol. Cancer21(1), 150 (2022).
  • Xin X , LiQ , FangJ , ZhaoT. LncRNA HOTAIR: a potential prognostic factor and therapeutic target in human cancers. Front. Oncol.11, 679244 (2021).
  • Smith NE , Spencer-MerrisP , FoxAH , PetersenJ , MichaelMZ. The long and the short of it: NEAT1 and cancer cell metabolism. Cancers14(18), 4388 (2022).
  • Xing C , SunSG , YueZQ , BaiF. Role of lncRNA LUCAT1 in cancer. Biomed. Pharmacother.134, 111158 (2021).
  • Kozlowska J , KolendaT , PoterPet al. Long intergenic non-coding RNAs in HNSCC: from €˜junk DNA€™ to important prognostic factor. Cancers13(12), 2949 (2021).
  • Botti G , CollinaF , ScognamiglioGet al. LncRNA HOTAIR polymorphisms association with cancer susceptibility in different tumor types. Curr. Drug Targets19(10), 1220€“1226 (2018).
  • Han X , WuJ , ZhangY , SongJ , ShiZ , ChangH. LINC00518 promotes cell proliferation by regulating the cell cycle of lung adenocarcinoma through miR-185-3p targeting MECP2. Front. Oncol.11, 646559 (2021).
  • Wang HB , WeiH , WangJS , LiL , ChenAY , LiZG. Down-regulated expression of LINC00518 prevents epithelial cell growth and metastasis in breast cancer through the inhibition of CDX2 methylation and the Wnt signaling pathway. Biochim. Biophys. Acta Mol. Basis Dis.1865(3), 708€“723 (2019).
  • Luan W , DingY , MaS , RuanH , WangJ , LuF. Long noncoding RNA LINC00518 acts as a competing endogenous RNA to promote the metastasis of malignant melanoma via miR-204-5p/AP1S2 axis. Cell Death Dis.10(11), 855 (2019).
  • He J , SunM , GengH , TianS. Long non-coding RNA Linc00518 promotes paclitaxel resistance of the human prostate cancer by sequestering miR-216b-5p. Biol. Cell111(2), 39€“50 (2019).
  • Sun D , WangJ , HanYet al. TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment. Nucleic Acids Res.49(D1), D1420€“D1430 (2021).
  • Tang Z , KangB , LiC , ChenT , ZhangZ. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res.47(W1), W556€“W560 (2019).
  • Cao Z , PanX , YangY , HuangY , ShenHB. The lncLocator: a subcellular localization predictor for long non-coding RNAs based on a stacked ensemble classifier. Bioinformatics34(13), 2185€“2194 (2018).
  • Tong Y , RuB , ZhangJ. miRNACancerMAP: an integrative web server inferring miRNA regulation network for cancer. Bioinformatics34(18), 3211€“3213 (2018).
  • Cerami E , GaoJ , DogrusozUet al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov.2(5), 401€“404 (2012).
  • Bo H , FanL , LiJet al. High expression of lncRNA AFAP1-AS1 promotes the progression of colon cancer and predicts poor prognosis. J. Cancer9(24), 4677–4683 (2018).
  • Wang Y , WangS , RenY , ZhouX. The role of lncRNA crosstalk in leading cancer metastasis of head and neck squamous cell carcinoma. Front. Oncol.10, 561833 (2020).
  • Sharma A , KansaraS , MahajanM , YadavB , GargM , PandeyAK. Long non-coding RNAs orchestrate various molecular and cellular processes by modulating epithelial–mesenchymal transition in head and neck squamous cell carcinoma. Biochim. Biophys. Acta Mol. Basis Dis.1867(11), 166240 (2021).
  • Barbagallo C , CaltabianoR , BroggiGet al. LncRNA LINC00518 acts as an oncogene in uveal melanoma by regulating an RNA-based network. Cancers12(12), 3867 (2020).
  • Wang DW , YouD , DongJ , LiuTF. Knockdown of long non-coding RNA LINC00518 inhibits cervical cancer proliferation and metastasis by modulating JAK/STAT3 signaling. Eur. Rev. Med. Pharmacol. Sci.23(2), 496–506 (2019).
  • Murugan AK . mTOR: role in cancer, metastasis and drug resistance. Semin. Cancer Biol.59, 92–111 (2019).
  • Harsha C , BanikK , AngHLet al. Targeting AKT/mTOR in oral cancer: mechanisms and advances in clinical trials. Int. J. Mol. Sci.21(9), 3285 (2020).
  • Wu Y , ZhangY , QinX , GengH , ZuoD , ZhaoQ. PI3K/AKT/mTOR pathway-related long non-coding RNAs: roles and mechanisms in hepatocellular carcinoma. Pharmacol. Res.160, 105195 (2020).
  • Noh JH , KimKM , McCluskyWG , AbdelmohsenK , GorospeM. Cytoplasmic functions of long noncoding RNAs. Wiley Interdiscip. Rev. RNA9(3), e1471 (2018).
  • Statello L , GuoCJ , ChenLL , HuarteM. Gene regulation by long non-coding RNAs and its biological functions. Nat. Rev. Mol. Cell Biol.22(2), 96–118 (2021).
  • Bueno-Urquiza LJ , Martinez-BarajasMG , Villegas-MercadoCEet al. The two faces of immune-related lncRNAs in head and neck squamous cell carcinoma. Cells12(5), 727 (2023).
  • Saadi W , FatmiA , PallardoFV , Garcia-GimenezJL , Mena-MollaS. Long non-coding RNAs as epigenetic regulators of immune checkpoints in cancer immunity. Cancers15 (1), 184 (2022).
  • Park EG , PyoSJ , CuiY , YoonSH , NamJW. Tumor immune microenvironment lncRNAs. Brief. Bioinform.23(1), bbab504 (2022).
  • Lee MJ , JinN , GrandisJR , JohnsonDE. Alterations and molecular targeting of the GSK-3 regulator, PI3K, in head and neck cancer. Biochim. Biophys. Acta Mol. Cell Res.1867(6), 118679 (2020).
  • Papalouka C , AdamakiM , BatsakiPet al. DNA damage response mechanisms in head and neck cancer: significant implications for therapy and survival. Int. J. Mol. Sci.24(3), 2760 (2023).
  • Liouta G , AdamakiM , TsintarakisAet al. DNA methylation as a diagnostic, prognostic, and predictive biomarker in head and neck cancer. Int. J. Mol. Sci.24(3), 2996 (2023).
  • van der Laan L , RooneyK , TroosterTM , MannensMM , SadikovicB , HennemanP. DNA methylation episignatures: insight into copy number variation. Epigenomics14(21), 1373–1388 (2022).
  • Sousa LO , SobralLM , de AlmeidaLO , GarciaCB , GreeneLJ , LeopoldinoAM. SET protein modulates H4 histone methylation status and regulates miR-137 level in oral squamous cell carcinoma. Epigenomics12(6), 475–485 (2020).
  • Liu Y , HeD , XiaoM , ZhuY , ZhouJ , CaoK. Long noncoding RNA LINC00518 induces radioresistance by regulating glycolysis through an miR-33a-3p/HIF-1alpha negative feedback loop in melanoma. Cell Death Dis.12(3), 245 (2021).
  • Gambi G , MengusG , DavidsonGet al. The lncRNA LENOX interacts with RAP2C to regulate metabolism and promote resistance to MAPK inhibition in melanoma. Cancer Res.82(24), 4555–4570 (2022).
  • Shen R , CaiX , ShenDet al. Long noncoding RNA LINC00518 contributes to proliferation and metastasis in lung adenocarcinoma via the miR-335-3p/CTHRC1 axis. Cell Death Discov.8(1), 98 (2022).
  • Hashemi M , RashidiM , HushmandiKet al. HMGA2 regulation by miRNAs in cancer: affecting cancer hallmarks and therapy response. Pharmacol. Res.190, 106732 (2023).
  • Mansoori B , MohammadiA , DitzelHJet al. HMGA2 as a critical regulator in cancer development. Genes12(2), 269 (2021).
  • Wang X , WangJ , WuJ. Emerging roles for HMGA2 in colorectal cancer. Transl. Oncol.14(1), 100894 (2021).
  • Chen RX , ChenX , XiaLPet al. N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis. Nat. Commun.10(1), 4695 (2019).
  • Kou N , LiuS , LiXet al. H19 facilitates tongue squamous cell carcinoma migration and invasion via sponging miR-let-7. Oncol. Res.27(2), 173–182 (2019).
  • Xue F , FengH , WangTet al. hsa_circ_0000264 promotes tumor progression via the hsa-let-7b-5p/HMGA2 axis in head and neck squamous cell carcinoma. Oral Disdoi:10.1111/odi.14399 (2022) ( Epub ahead of print).
  • Carrabotta M , LaginestraMA , DuranteGet al. Integrated molecular characterization of patient-derived models reveals therapeutic strategies for treating CIC-DUX4 sarcoma. Cancer Res.82(4), 708–720 (2022).
  • Tan L , WeiX , ZhengLet al. Amplified HMGA2 promotes cell growth by regulating Akt pathway in AML. J. Cancer Res. Clin.142(2), 389–399 (2016).
  • Ferris RL . Immunology and immunotherapy of head and neck cancer. J. Clin. Oncol.33(29), 3293–3304 (2015).
  • Elmusrati A , WangJ , WangCY. Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma. Int. J. Oral Sci.13(1), 24 (2021).
  • Li H , YangZ , YangXet al. LINC01123 promotes immune escape by sponging miR-214-3p to regulate B7-H3 in head and neck squamous-cell carcinoma. Cell Death Dis.13(2), 109 (2022).
  • Zhou Z , LiuQ , ZhangGet al. HOXA11-AS1 promotes PD-L1-mediated immune escape and metastasis of hypopharyngeal carcinoma by facilitating PTBP1 and FOSL1 association. Cancers14(15), 3694 (2022).
  • Wang J , YangC , CaoHet al. Hypermethylation-mediated lncRNA MAGI2-AS3 downregulation facilitates malignant progression of laryngeal squamous cell carcinoma via interacting with SPT6. Cell Transplant.32, 63754866 (2023).
  • Yang W , ZhouJ , ZhangZet al. Downregulation of lncRNA APCDD1L-AS1 due to DNA hypermethylation and loss of VHL protein expression promotes the progression of clear cell renal cell carcinoma. Int. J. Biol. Sci.18(6), 2583–2596 (2022).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.